Boston Scientific Corp.'s Farapoint, its latest pulsed field ablation catheter, received U.S. FDA approval for use as an ...

Executives from the Marlborough, MA-based company discussed its position in the fast-growing pulsed-field ablation market.

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.

Medtronic CEO Geoff Martha shed some light on the company's M&A strategy this week at the J.P. Morgan Healthcare Conference.

Medtronic asserted that key markets it targets including PFA and renal denervation represent lucrative opportunities in the ...

A Boston Scientific executive said that the company received FDA approval for its Farapoint pulsed field ablation (PFA) ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

Field Medical Inc., a clinical-stage medical technology company advancing a versatile, next-generation pulsed field ablation ...

In recent days, Boston Scientific has drawn upbeat commentary from Wall Street, with analysts citing strong demand across ...

Luma Vision announced that it completed 15 AFib ablation procedures as part of a clinical study in collaboration with CardioFocus.

LUMA Vision Ltd., a leader in cardiac 4D navigation and imaging, today announced the successful completion of 15 ...